IBDEI0A0 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13244,1,5,0)
 ;;=5^H/O Testicular Cancer
 ;;^UTILITY(U,$J,358.3,13244,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,13245,0)
 ;;=V10.83^^86^785^61
 ;;^UTILITY(U,$J,358.3,13245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13245,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,13245,1,5,0)
 ;;=5^H/O Skin Cancer
 ;;^UTILITY(U,$J,358.3,13245,2)
 ;;=H/O Skin Cancer^295241
 ;;^UTILITY(U,$J,358.3,13246,0)
 ;;=285.22^^86^785^7
 ;;^UTILITY(U,$J,358.3,13246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13246,1,4,0)
 ;;=4^285.22
 ;;^UTILITY(U,$J,358.3,13246,1,5,0)
 ;;=5^Anemia In Cancer
 ;;^UTILITY(U,$J,358.3,13246,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,13247,0)
 ;;=285.21^^86^785^8
 ;;^UTILITY(U,$J,358.3,13247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13247,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,13247,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,13247,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,13248,0)
 ;;=285.29^^86^785^9
 ;;^UTILITY(U,$J,358.3,13248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13248,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,13248,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,13248,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,13249,0)
 ;;=284.9^^86^785^10
 ;;^UTILITY(U,$J,358.3,13249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13249,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,13249,1,5,0)
 ;;=5^Aplastic Anemia Nos
 ;;^UTILITY(U,$J,358.3,13249,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,13250,0)
 ;;=282.61^^86^785^66
 ;;^UTILITY(U,$J,358.3,13250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13250,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,13250,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,13250,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,13251,0)
 ;;=282.7^^86^785^65
 ;;^UTILITY(U,$J,358.3,13251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13251,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,13251,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,13251,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,13252,0)
 ;;=283.9^^86^785^68
 ;;^UTILITY(U,$J,358.3,13252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13252,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,13252,1,5,0)
 ;;=5^Hemolytic Anemia , Acquired
 ;;^UTILITY(U,$J,358.3,13252,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,13253,0)
 ;;=283.0^^86^785^69
 ;;^UTILITY(U,$J,358.3,13253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13253,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,13253,1,5,0)
 ;;=5^Hemolytic Anemia, Autoimmune
 ;;^UTILITY(U,$J,358.3,13253,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,13254,0)
 ;;=282.9^^86^785^67
 ;;^UTILITY(U,$J,358.3,13254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13254,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,13254,1,5,0)
 ;;=5^Hemolytic Anem, Heredit
 ;;^UTILITY(U,$J,358.3,13254,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,13255,0)
 ;;=283.19^^86^785^70
 ;;^UTILITY(U,$J,358.3,13255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13255,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,13255,1,5,0)
 ;;=5^Hemolytic Anemia, Microang
 ;;^UTILITY(U,$J,358.3,13255,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,13256,0)
 ;;=280.9^^86^785^74
 ;;^UTILITY(U,$J,358.3,13256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13256,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,13256,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,13256,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,13257,0)
 ;;=285.1^^86^785^72
 ;;^UTILITY(U,$J,358.3,13257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13257,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,13257,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,13257,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,13258,0)
 ;;=280.0^^86^785^73
 ;;^UTILITY(U,$J,358.3,13258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13258,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,13258,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,13258,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,13259,0)
 ;;=281.9^^86^785^92
 ;;^UTILITY(U,$J,358.3,13259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13259,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,13259,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,13259,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,13260,0)
 ;;=281.0^^86^785^109
 ;;^UTILITY(U,$J,358.3,13260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13260,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,13260,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,13260,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,13261,0)
 ;;=282.60^^86^785^99
 ;;^UTILITY(U,$J,358.3,13261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13261,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,13261,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,13261,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,13262,0)
 ;;=282.62^^86^785^100
 ;;^UTILITY(U,$J,358.3,13262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13262,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,13262,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,13262,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,13263,0)
 ;;=281.1^^86^785^110
 ;;^UTILITY(U,$J,358.3,13263,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13263,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,13263,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,13263,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,13264,0)
 ;;=286.7^^86^785^44
 ;;^UTILITY(U,$J,358.3,13264,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13264,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,13264,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,13264,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,13265,0)
 ;;=289.9^^86^785^106
 ;;^UTILITY(U,$J,358.3,13265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13265,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,13265,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,13265,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,13266,0)
 ;;=451.9^^86^785^107
 ;;^UTILITY(U,$J,358.3,13266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13266,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,13266,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,13266,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,13267,0)
 ;;=446.6^^86^785^108
 ;;^UTILITY(U,$J,358.3,13267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13267,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,13267,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,13267,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,13268,0)
 ;;=286.4^^86^785^111
 ;;^UTILITY(U,$J,358.3,13268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13268,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,13268,1,5,0)
 ;;=5^Von Willebrand'S Disease
 ;;^UTILITY(U,$J,358.3,13268,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,13269,0)
 ;;=204.00^^86^785^4
 ;;^UTILITY(U,$J,358.3,13269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13269,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,13269,1,5,0)
 ;;=5^All, W/O Remission
 ;;^UTILITY(U,$J,358.3,13269,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,13270,0)
 ;;=204.01^^86^785^3
 ;;^UTILITY(U,$J,358.3,13270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13270,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,13270,1,5,0)
 ;;=5^All, In Remission
 ;;^UTILITY(U,$J,358.3,13270,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,13271,0)
 ;;=204.10^^86^785^41
 ;;^UTILITY(U,$J,358.3,13271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13271,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,13271,1,5,0)
 ;;=5^Cll, W/O Remission
 ;;^UTILITY(U,$J,358.3,13271,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,13272,0)
 ;;=204.11^^86^785^40
 ;;^UTILITY(U,$J,358.3,13272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13272,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,13272,1,5,0)
 ;;=5^Cll, In Remission
 ;;^UTILITY(U,$J,358.3,13272,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,13273,0)
 ;;=201.90^^86^785^71
 ;;^UTILITY(U,$J,358.3,13273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13273,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,13273,1,5,0)
 ;;=5^Hodgkin'S Lymphoma, Unpsec Type & Site
 ;;^UTILITY(U,$J,358.3,13273,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,13274,0)
 ;;=785.6^^86^785^77
 ;;^UTILITY(U,$J,358.3,13274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13274,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,13274,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,13274,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,13275,0)
 ;;=200.20^^86^785^78
 ;;^UTILITY(U,$J,358.3,13275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13275,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,13275,1,5,0)
 ;;=5^Lymphoma, Burkitt'S, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,13275,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,13276,0)
 ;;=202.00^^86^785^80
 ;;^UTILITY(U,$J,358.3,13276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13276,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,13276,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,13276,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,13277,0)
 ;;=200.10^^86^785^79
 ;;^UTILITY(U,$J,358.3,13277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13277,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,13277,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,13277,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,13278,0)
 ;;=273.3^^86^785^81
 ;;^UTILITY(U,$J,358.3,13278,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13278,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,13278,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,13278,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,13279,0)
 ;;=203.00^^86^785^90
 ;;^UTILITY(U,$J,358.3,13279,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13279,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,13279,1,5,0)
 ;;=5^Multiple Myeloma W/O Rem
 ;;^UTILITY(U,$J,358.3,13279,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,13280,0)
 ;;=203.01^^86^785^89
 ;;^UTILITY(U,$J,358.3,13280,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13280,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,13280,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,13280,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,13281,0)
 ;;=238.6^^86^785^93
 ;;^UTILITY(U,$J,358.3,13281,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,13281,1,4,0)
 ;;=4^238.6
